José Antonio García Marco

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia

Francesc Bosch, Pau Abrisqueta, Neus Villamor et al. · Journal of Clinical Oncology · 2009 · 127 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Haplo-Cord Transplantation Using CD34+ Cells from a Third-Party Donor to Speed Engraftment in High-Risk Patients with Hematologic Disorders

Mi Kwon, Guiomar Bautista, Pascual Balsalobre et al. · Biology of Blood and Marrow Transplantation · 2014 · 44 citations · Full text

Medicine, Hematology, Cell Therapy +16

First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.

John C. Byrd, Peter Hillmen, Paolo Ghia et al. · Journal of Clinical Oncology · 2021 · 38 citations

Medicine, Oncology, Pharmacology +14

Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells

Diego Sánchez‐Martínez, Pilar M. Lanuza, Natalia Gómez et al. · Frontiers in Immunology · 2016 · 30 citations · Full text

Life Sciences, Immunology, Oncology +17

A phase III, randomized, controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).

Ian W. Flinn, Eva Kimby, Finbarr E. Cotter et al. · Journal of Clinical Oncology · 2013 · 20 citations

Life Sciences, Immunology, Pharmacology +17